Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Hypersensitivity Reaction

Free Subscription 08.09.2025 4 Allergy 9 Ann Allergy Asthma Immunol 2 Br J Dermatol 4 Int Arch Allergy Immunol 2 J Allergy Clin Immunol 5 J Am Acad Dermatol 2 J Invest Dermatol 2 Pediatr Dermatol 1 Pediatrics 2 PLoS One 12 Respir Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Allergy

1. BOUSSAND M, Castaing-Lasvignottes ME, Leopold K, Bourgoin P, et al
   A Streamlined Miniaturized and Multi-Allergen Basophil Activation Test Platform Amenable to Population-Based Study.
   Allergy. 2025 Sep 5. doi: 10.1111/all.70040.
   PubMed        
   
   
2. WATANABE S, Sato A, Seki H, Kawauchi Y, et al
   Health-Related Quality of Life in Adults With Food Protein-Induced Enterocolitis Syndrome: Generic Versus Allergy-Specific Tools.
   Allergy. 2025 Sep 4. doi: 10.1111/all.70041.
   PubMed        
   
   
3. CAIN J, Hurrell B, Akbari O
   The Expanding Role of ILC2s in Allergic Airways Disease.
   Allergy. 2025 Sep 2. doi: 10.1111/all.70030.
   PubMed         Abstract available
   
   
4. HUANG HJ, Breyer-Kohansal R, Niespodziana K, Lim CJM, et al
   Molecular IgE Sensitization Profiling With Micro-Arrayed Allergen Molecules in Adult Patients With Asthma From the LEAD Cohort: A Precision Medicine Approach.
   Allergy. 2025 Aug 30. doi: 10.1111/all.70017.
   PubMed         Abstract available
   
   

   
   Ann Allergy Asthma Immunol

5. NGUYEN VT, Roth K, Engelhardt E, Pearlstein A, et al
   The usual suspects: Respiratory Syncytial Virus and Rhinovirus drive asthma development and exacerbation.
   Ann Allergy Asthma Immunol. 2025 Apr 24:S1081-1206(25)00205.
   PubMed         Abstract available
   
   
6. MA R, Zhang C, Zhang Y, Tan H, et al
   The Impact of Respiratory Syncytial Virus on Asthma Development and Exacerbation.
   Ann Allergy Asthma Immunol. 2025 May 17:S1081-1206(25)00236.
   PubMed         Abstract available
   
   
7. CASTALDO AJ, Wells KE, Khalid S, Rashidi E, et al
   Establishing a hereditary angioedema prevalence for the United States using a large administrative claims database.
   Ann Allergy Asthma Immunol. 2025;135:303-310.
   PubMed         Abstract available
   
   
8. JAROENPUNTARUK V, Jenkins SM, Smith CY, Gonzalez-Estrada A, et al
   Sex differences in urinary mast cell mediators: Implications for diagnosing atopic and mast cell disorders.
   Ann Allergy Asthma Immunol. 2025;135:320-327.
   PubMed         Abstract available
   
   
9. FARKAS H, Peter JG, Stobiecki M, Anderson J, et al
   Long-term safety and efficacy of once-daily berotralstat in patients with hereditary angioedema: APeX-S final results.
   Ann Allergy Asthma Immunol. 2025;135:311-319.
   PubMed         Abstract available
   
   
10. HENAO MP, Malerich J, George DR
    Impact of Language Barriers on Pulmonary Function and Asthma Control.
    Ann Allergy Asthma Immunol. 2025 Jun 8:S1081-1206(25)00278.
    PubMed         Abstract available
    
    
11. RAYNER DG, Bakaa L, Hoyte F, Perry TT, et al
    Triple therapy versus dual inhaler therapy for moderate-to-severe asthma: an updated systematic review and meta-analysis.
    Ann Allergy Asthma Immunol. 2025 Jun 12:S1081-1206(25)00287.
    PubMed         Abstract available
    
    
12. ABDELKADER S, Voladri DR, Kennedy JL
    Beyond respiratory syncytial virus and rhinovirus: The other viral respiratory bandits.
    Ann Allergy Asthma Immunol. 2025;135:249-260.
    PubMed         Abstract available
    
    
13. GUPTA A
    Translational significance of endogenous epinephrine suppression in allergic states: A dermatologic perspective.
    Ann Allergy Asthma Immunol. 2025;135:349.
    PubMed        
    
    

    
    Br J Dermatol

14. ZHANG J, Silverberg JI, Guo J, Yun J, et al
    Rademikibart monotherapy for moderate-to-severe atopic dermatitis in a 1-year, randomized, phase II trial (SEASIDE CHINA): initial two-week dosing, followed by two-week or four-week dosing.
    Br J Dermatol. 2025 Sep 2:ljaf347. doi: 10.1093.
    PubMed         Abstract available
    
    
15. OLESEN CM, Agner T
    Can food allergy be prevented by handwashing?
    Br J Dermatol. 2025 Aug 30:ljaf283. doi: 10.1093.
    PubMed        
    
    

    
    Int Arch Allergy Immunol

16. DZAFIC F, Ahmetovic A, Coloman N, Dzafic I, et al
    Interpretation of the Diagnostic Accuracy of the Nasal Allergy Test.
    Int Arch Allergy Immunol. 2025 Sep 4:1-15. doi: 10.1159/000548221.
    PubMed         Abstract available
    
    
17. OHARA Y, Matsumoto Y, Fujita M, Inuo C, et al
    Comparative Safety of Baked Egg, Egg Yolk, and Egg White in Young Children with Egg Allergy.
    Int Arch Allergy Immunol. 2025 Sep 3:1-13. doi: 10.1159/000548298.
    PubMed         Abstract available
    
    
18. ZHANG B, Li J, Zhang L, Zhang Y, et al
    Mouse Models for Studying the Mechanisms and Therapeutic Effects of Allergic Airway Inflammation.
    Int Arch Allergy Immunol. 2025 Sep 1:1-13. doi: 10.1159/000548101.
    PubMed         Abstract available
    
    
19. JANG W, Jo H, Park J, Kim S, et al
    Use of biologics to treat asthma during pregnancy and adverse events in pregnant women and newborns: A global pharmacovigilance analysis.
    Int Arch Allergy Immunol. 2025 Jan 17:1-21. doi: 10.1159/000543490.
    PubMed         Abstract available
    
    

    
    J Allergy Clin Immunol

20. LU Z, Petersen C, Dai R, Reyna ME, et al
    Early preschool wheeze trajectories are predominantly non-allergic with distinct biologic and microbiome traits.
    J Allergy Clin Immunol. 2025 Sep 3:S0091-6749(25)00933.
    PubMed         Abstract available
    
    
21. BRUGGEMANN TR, Tavares LP, Almanzar N, Singh D, et al
    Traffic-emitted ultrafine particles disrupt macrophage efferocytosis and resolution of allergic lung inflammation.
    J Allergy Clin Immunol. 2025 Sep 1:S0091-6749(25)00896.
    PubMed         Abstract available
    
    

    
    J Am Acad Dermatol

22. WANG Y, Liu Z
    Comments on "Abrocitinib versus dupilumab: impact on skin barrier function and proteomics in atopic dermatitis".
    J Am Acad Dermatol. 2025 Aug 29:S0190-9622(25)02698.
    PubMed        
    
    
23. CLABBERS J, Boesjes C, van Geel M, de Bruin-Weller M, et al
    Response to Bissonnette et al. 'Dupilumab treatment restores lesional and nonlesional skin barrier function in adults and adolescents with atopic dermatitis irrespective of the filaggrin genotype: Results from an open-label, healthy-control-matched, p
    J Am Acad Dermatol. 2025 Aug 29:S0190-9622(25)02703.
    PubMed        
    
    
24. BISSONNETTE R, Goleva E, Berdyshev E, Leung DYM, et al
    In response to: "Response to Bissonnette et al. Dupilumab treatment restores lesional and non-lesional skin barrier function in adults and adolescents with atopic dermatitis irrespective of the filaggrin genotype: Results from an open-label, healthy.
    J Am Acad Dermatol. 2025 Aug 29:S0190-9622(25)02705.
    PubMed        
    
    
25. CHANG JW, Wang F
    Response to Wang et al., "Comments on 'Abrocitinib versus dupilumab: impact on skin barrier function and proteomics in atopic dermatitis'".
    J Am Acad Dermatol. 2025 Aug 29:S0190-9622(25)02699.
    PubMed        
    
    
26. LU J, Wang Y, Zhou C, Deng L, et al
    Increased Cancer Risk and Mortality in Individuals with Atopic Dermatitis: Evidence from the NHANES.
    J Am Acad Dermatol. 2025 Sep 1:S0190-9622(25)02726.
    PubMed        
    
    

    
    J Invest Dermatol

27. KROGH NS, Prieto-Merino D, Coker B, Birkner T, et al
    Implementing Federated Analysis using DataSHIELD in the DREAM TO TREAT Atopic Dermatitis Registries Collaboration.
    J Invest Dermatol. 2025 Sep 3:S0022-202X(25)02407.
    PubMed         Abstract available
    
    
28. WANG Q, Qiu Q, Sun H, Liu Y, et al
    Distinct Comorbidity Clusters and Their Genetic Associations with Atopic Dermatitis in Middle-Aged and Elderly Adults.
    J Invest Dermatol. 2025 Sep 2:S0022-202X(25)02404.
    PubMed        
    
    

    
    Pediatr Dermatol

29. CHAN CJ, Visscher MO
    Prevention of Atopic Dermatitis in High-Risk Infants: A Review of the Role of Lipid-Based Barrier Repair Therapy.
    Pediatr Dermatol. 2025 Sep 4. doi: 10.1111/pde.70010.
    PubMed         Abstract available
    
    
30. BRUESS GES, Barry KK, Olsen GM, Foschi CM, et al
    Evaluating Outcomes of Live-Attenuated Vaccine Administration in Pediatric Patients on Dupilumab for Atopic Dermatitis.
    Pediatr Dermatol. 2025 Sep 2. doi: 10.1111/pde.70033.
    PubMed         Abstract available
    
    

    
    Pediatrics

31. CHEUNG CR, Butler M, Cooper C, Dhanoa H, et al
    Using Artificial Intelligence and Machine Learning to Promote Child Health Equity.
    Pediatrics. 2025;156.
    PubMed         Abstract available
    
    

    
    PLoS One

32. WANG M, Wang S, Lin X, Lv X, et al
    Identification of immune-related biomarkers associated with allergic rhinitis and development of a sample diagnostic model.
    PLoS One. 2025;20:e0329549.
    PubMed         Abstract available
    
    
33. MITRI EA, Fletcher LR, Paynter C, Vogrin S, et al
    International Network of Antibiotic Allergy Nations (iNAAN): Protocol for a type 2 hybrid effectiveness-implementation multicentre prospective cohort and target trial emulation study evaluating penicillin allergy delabeling via direct oral challenge.
    PLoS One. 2025;20:e0330724.
    PubMed         Abstract available
    
    

    
    Respir Med

34. HOGAARD NV, Sigsgaard T, Agertoft L, Halken S, et al
    Effect of indoor environmental interventions in the home on asthma in children and adolescents: A systematic review.
    Respir Med. 2025 Aug 5:108299. doi: 10.1016/j.rmed.2025.108299.
    PubMed         Abstract available
    
    
35. PATEL C, Sheth V, Koppula R, Kumar A, et al
    Efficacy and safety of novel fixed dose combination of vilanterol, glycopyrronium, and fluticasone furoate dry powder inhaler: A phase 3, randomized, non-inferiority trial compared with fixed dose combination of indacaterol, glycopyrronium, and mometa
    Respir Med. 2025;247:108293.
    PubMed         Abstract available
    
    
36. HU Y, Hu Y, Dong M, Zheng S, et al
    Integrating clinical phenotypes, impulse oscillometry and fractional exhaled nitric oxide: a robust machine learning model for early asthma prediction in preschool children.
    Respir Med. 2025 Aug 1:108290. doi: 10.1016/j.rmed.2025.108290.
    PubMed         Abstract available
    
    
37. TU D, Ju S, Xue Y, Xie W, et al
    Association between asthma and advanced cardiovascular-kidney-metabolic syndrome in U.S. adults, a cross-sectional study from NHANES 2011-2023.
    Respir Med. 2025;247:108288.
    PubMed         Abstract available
    
    
38. VERMA B, Kumar N, Ashique S, Debnath B, et al
    Probiotics: An adjuvant treatment strategy for chronic respiratory diseases.
    Respir Med. 2025;247:108268.
    PubMed         Abstract available
    
    
39. TIRELLI C, Parazzini EM, Sacchi L, Carone G, et al
    Forced Oscillatory Technique R5-19 values correlate with spirometry FEV1/FVC in severe eosinophilic asthma. An observational, prospective, cohort study.
    Respir Med. 2025 Jul 16:108260. doi: 10.1016/j.rmed.2025.108260.
    PubMed         Abstract available
    
    
40. PARK HJ, Lee CH, Lee JK, Kim DK, et al
    Radiologic emphysema predicts accelerated lung function decline in patients with asthma.
    Respir Med. 2025;247:108261.
    PubMed         Abstract available
    
    
41. KOH MS, Xu X, Wei Lam SS, Wu JT, et al
    Public health insights of patients with asthma receiving primary, specialist or mixed care in Singapore using data from the SDG-CARE Asthma Registry.
    Respir Med. 2025 Jul 11:108252. doi: 10.1016/j.rmed.2025.108252.
    PubMed         Abstract available
    
    
42. ACHTERBOSCH M, Hansen CME, Brand PLP, van Dijk L, et al
    Shared decision making and inhaled medication adherence in patients with COPD, asthma and cystic fibrosis: a systematic review.
    Respir Med. 2025 Jul 11:108251. doi: 10.1016/j.rmed.2025.108251.
    PubMed        
    
    
43. BRAIDO F, Beeh KM, Serrano CC, Dinh-Xuan AT, et al
    Real-world use of beclometasone dipropionate and formoterol fumarate NEXThaler(R) and asthma control among adult asthmatic patients in Europe: The results of the NEWTON Study.
    Respir Med. 2025 Jul 9:108224. doi: 10.1016/j.rmed.2025.108224.
    PubMed         Abstract available
    
    
44. OTTEN B, Weinberg D, Gregoski MJ, James WE, et al
    Management of anti-drug antibodies against TNF-inhibitors in sarcoidosis patients.
    Respir Med. 2025;247:108301.
    PubMed         Abstract available
    
    
45. GREIG R, Suter P, Chan R, Lipworth B, et al
    Impact of dupilumab on oscillometry and spirometry derived ratios in severe refractory asthma.
    Respir Med. 2025;247:108315.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge.